Demolition work is underway at RiverGate Mall in the Goodlettsville area, paving way for a planned $450M redevelopment.

Bulldozers, piles of rubble and dump trucks are the first steps towards the ambitious effort to remake the RiverGate Mall ...

On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell lung ...

Merus (MRUS) keeps catching attention as its shares post impressive gains over the past month, rising around 46%. Recent investor interest appears closely linked to ongoing optimism around the company ...

The master plan by Cincinnati-based Merus shows a three-phase project that includes two buildings totaling more than 698,000 ...

Merus (NASDAQ:MRUS) has observed the following analyst ratings within the last quarter: In the last 3 months, 19 analysts have offered 12-month price targets for Merus. The company has an average ...

Merus’ NRG1 gene targeting cancer treatment helped to shrink tumors and kept working for up to 9.1 months, leaving the company’s leadership with an important question: partner up or go it alone for ...

Shares of Merus N.V. (NASDAQ:MRUS) added ~16% in the premarket on Friday after the Dutch biotech posted interim data from a mid-stage trial designed to test its lead candidate, petosemtamab, in ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where Merus N.V. (NASDAQ:MRUS) stands against other best cancer ...

Merus N.V. (NASDAQ:MRUS) stock moved lower on Monday. The company announced a research collaboration and license agreement with Biohaven Ltd. (NYSE:BHVN). Here’s what you need to know. What To Know: ...

YLÖJÄRVI, Finland, February 11, 2026--(BUSINESS WIRE)--Merus Power Oyj has signed a battery energy storage deal worth approximately 13 million euros with Neve Oy. The 30 MW/80 MWh facility is designed ...